ATNM   $1.81  5.23% Market Closed After Close 1.84 1.66%

Actinium Pharmaceuticals Inc
Total Cash 86.04M
totalCashPerShare 2.762
EBITDA -46.48M
Total Debt 1.85M
quickRatio 8.844
currentRatio 8.95
Total Revenue 81.00K
debtToEquity 4.218
Revenue/Share 0.003
ROA -0.30907
ROE -0.87961996
grossProfits
freeCashflow -20.06M
operatingCashflow -33.96M
earningsGrowth
revenueGrowth
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -576.65436
profitMargins 0.0
enterpriseValue -29.67M
forwardPE -2.536232
floatShares 30.37M
sharesOutstanding 31.15M
sharesShort 1.97M
sharesShortPriorMonth 2.22M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.28%
Short Ratio help_outline 5.97%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue 1.435
Price To Book help_outline 1.22
earningsQuarterlyGrowth
netIncomeToCommon -42.62M
trailingEps -1.51%
forwardEps -0.69%
enterpriseToEbitda 0.64
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.34 3Q 2024
institutionsCount 110
lastUpdated Oct. 16, 2024, 12:32 p.m.